Safilo Group S.p.A. (SAFLY)
OTCMKTS
· Delayed Price · Currency is USD
2.290
0.00 (0.00%)
At close: Jul 1, 2025
Safilo Group Revenue
In the year 2024, Safilo Group had annual revenue of 993.22M EUR, down -3.08%. Safilo Group had revenue of 461.26M in the half year ending December 31, 2024, a decrease of -8.82%.
Revenue
993.22M EUR
Revenue Growth
-3.08%
P/S Ratio
0.43
Revenue / Employee
272.49K EUR
Employees
3,645
Market Cap
446.55M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |